January 2014 - Volume 35 - Issue 1
pp: 1-111


Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer

Challapalli, Amarnath; Barwick, Tara; Tomasi, Giampaolo; More

Nuclear Medicine Communications . 35(1):20-29, January 2014.

Correlation of 18F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with 18F-FDG PET

Norikane, Takashi; Yamamoto, Yuka; Maeda, Yukito; More

Nuclear Medicine Communications . 35(1):30-35, January 2014.

The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers

Kaida, Hayato; Kawahara, Akihiko; Hayakawa, Masanobu; More

Nuclear Medicine Communications . 35(1):36-43, January 2014.

Technetium-99m methoxyisobutylisonitrile scintigraphy in the assessment of cold thyroid nodules: is it time to change the approach to the management of cold thyroid nodules?

Riazi, Ahmad; Kalantarhormozi, Mohammadreza; Nabipour, Iraj; More

Nuclear Medicine Communications . 35(1):51-57, January 2014.

The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy

van Hoorn, Ralph A.; Vriens, Dennis; Postema, Jan-Willem A.; More

Nuclear Medicine Communications . 35(1):64-72, January 2014.

Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer

Borsò, Elisa; Boni, Giuseppe; Pastina, Ilaria; More

Nuclear Medicine Communications . 35(1):88-94, January 2014.